secwatch.observer — SEC 8-K summary
======================================

Issuer:     AN2 Therapeutics, Inc. (ANTX)
CIK:        0001880438
Form:       8-K
Filed at:   2025-06-11T23:59:59+00:00
Accession:  0001193125-25-138796
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AN2 Therapeutics posts updated investor presentation with no new material facts
-------------------------------------------------------------------------------

- Filed 8-K under Item 7.01 furnishing an updated investor presentation dated June 2025.
- No specific financial results, pipeline updates, or guidance changes disclosed in the filing.
- Presentation available on the 'Investors' section of the company's website.
- No material information beyond the routine investor update was provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1880438/000119312525138796/0001193125-25-138796-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1880438/000119312525138796/d812980d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-138796

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer